Bing Xia
Impact in
- Molecular Biology top 0.5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Genetics top 0.5%
- BRCA gene mutations in cancer
Papers in
-
- DNA Repair Mechanisms 37
- CRISPR and Genetic Engineering 18
- RNA and protein synthesis mechanisms 9
- Genetics 51
- BRCA gene mutations in cancer 23
- Inflammatory Bowel Disease 14
- Co-authors
- Masayori Inouye (10 shared papers)David M. Livingston (7 shared papers)Dima Kozakov (6 shared papers)Sándor Vajda (5 shared papers)Eileen White (3 shared papers)Jessie Yanxiang Guo (2 shared papers)Hong Cai (7 shared papers)Kathryn A. Porter (3 shared papers)
- Journals
- Molecular Cell (6 papers)Cancer Research (6 papers)World Journal of Gastroenterology (5 papers)Annals of Oncology (5 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bing Xia
257 papers receiving 11.6k citations
Bing Xia's Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Biology 7.4k
- Genetics 2.8k
- Cancer Research 1.4k
- Oncology 2.3k
- Immunology 713
Countries citing papers authored by Bing Xia
This map shows the geographic impact of Bing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xia more than expected).
Fields of papers citing papers by Bing Xia
This network shows the impact of papers produced by Bing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xia. The network helps show where Bing Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2 Hit paper breakdown → | 2006 | 687 |
| 2 | 2007 | 571 | |
| 3 | Performance and Its Limits in Rigid Body Protein-Protein Docking Hit paper breakdown → | 2020 | 507 |
| 4 | New additions to the C lus P ro server motivated by CAPRI Hit paper breakdown → | 2016 | 452 |
| 5 | 2009 | 443 | |
| 6 | 2013 | 423 | |
| 7 | 2007 | 375 | |
| 8 | 2006 | 375 | |
| 9 | 2000 | 338 | |
| 10 | 2004 | 299 | |
| 11 | 2011 | 282 | |
| 12 | 2010 | 253 | |
| 13 | 2001 | 191 | |
| 14 | 2007 | 180 | |
| 15 | 2012 | 166 | |
| 16 | 2010 | 165 | |
| 17 | 2017 | 154 | |
| 18 | 2017 | 151 | |
| 19 | 2006 | 140 | |
| 20 | 1996 | 134 |
About Bing Xia
Bing Xia is a scholar working on Molecular Biology, Genetics, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 269 papers that have together received 11.8k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (37 papers), BRCA gene mutations in cancer (23 papers), Lung Cancer Treatments and Mutations (22 papers), CRISPR and Genetic Engineering (18 papers), Inflammatory Bowel Disease (14 papers), Lung Cancer Research Studies (14 papers), PARP inhibition in cancer therapy (10 papers) and RNA and protein synthesis mechanisms (9 papers). The work is most often cited by research in Molecular Biology (7.4k citations), Genetics (2.8k citations), Cancer Research (1.4k citations), Oncology (2.3k citations) and Immunology (713 citations). Bing Xia has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Masayori Inouye, David M. Livingston, Dima Kozakov, Sándor Vajda, Eileen White, Jessie Yanxiang Guo, Hong Cai, Kathryn A. Porter, Haiping Ke and Tzeh Keong Foo. Their work appears in journals such as Molecular Cell, Cancer Research, World Journal of Gastroenterology, Annals of Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.